# Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations

> **NCT03714685** · PHASE1 · COMPLETED · sponsor: **Quantum Genomics SA** · enrollment: 12 (actual)

## Conditions studied

- Healthy Males

## Interventions

- **DRUG:** Firibastat

## Key facts

- **NCT ID:** NCT03714685
- **Lead sponsor:** Quantum Genomics SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-15
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-06-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03714685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03714685, "Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03714685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*